tirzepatide no longer in shortage Semaglutide and Shortage: All You Need to Know Some patients fear tirzepatide, sold

When the FDA removed tirzepatide from the drug shortage list in October 2024 and subsequently ended enforcement discretion for compounding, pharmacies needed to demonstrate that their compounded products were not "essentially a copy" of the commercially available branded version (Mounjaro/Zepbound)

Mounjaro , the first FDA-approved tirzepatide for type 2 diabetes, triggered the initial shortage

sovrappeso, cio con BMI tra 27 e 30 , se presente almeno una condizione correlata al peso, come ipertensione, dislipidemia, apnea ostruttiva del sonno, prediabete, malattia cardiovascolare o diabete di tipo 2

Compounded tirzepatide is a dual agonist, meaning it activates two hormonal receptors simultaneously: the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor

4

This innovative medication works by mimicking natural hormones that regulate appetite and calorie intake, making it an exceptional tool in the fight against obesity